Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines Review

Page last updated: 7 April 2016

The public consultation process on the draft revised PBAC Guidelines (Version 5.0) is now closed.  The submissions received will be considered for inclusion in the finalisation of the revised PBAC Guidelines.

It should be noted that the consultation process for the assessment of co-dependent technology chapter of the draft revised PBAC Guidelines, which is undergoing a separate submission process, will close on 11 April 2016. 

Further information on the Review is available on the PBAC Guidelines Review page.